Insider Shareholders with Direct Ownership of Akero Therapeutics, Inc. (AKRO)
This section provides a comprehensive overview of the insiders with direct ownership of Akero Therapeutics, Inc. (AKRO). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Akero Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Andrew Cheng
President and CEO |
878,349 | 600,758 | 605,417 $16.7 Million | 72 |
Sep 10, 2024
Reduced 0.29%
|
|
Jonathan Young
Chief Operating Officer |
221,247 | 181,528 | 226,286 $6.26 Million | 43 |
Oct 01, 2024
Reduced 4.23%
|
|
Timothy Rolph
Chief Scientific Officer |
145,676 | 218,409 | 180,705 $5 Million | 29 |
Sep 10, 2024
Reduced 0.3%
|
| 0 | 169,065 | 136,301 $3.77 Million | 5 |
Nov 30, 2022
Reduced 3.39%
|
|
|
Catriona Yale
Chief Development Officer |
115,437 | 205,324 | 75,294 $2.08 Million | 44 |
Sep 20, 2024
Reduced 6.81%
|
|
William Richard White
Chief Financial Officer |
533,781 | 494,661 | 41,152 $1.14 Million | 53 |
Sep 10, 2024
Reduced 1.53%
|
|
Patrick Lamy
Senior VP, Commercial Strategy |
18,791 | 569 | 18,783 $519,349 | 3 |
Jun 28, 2024
Added 1.16%
|
| 26,000 | 26,000 | 0 $0 | 2 |
Jun 16, 2023
Reduced 100.0%
|
|
| 40,000 | 40,000 | 0 $0 | 2 |
Jun 16, 2023
Reduced 100.0%
|
|
|
Apple Tree Partners Iv, L.P.
> 10% Shareholder |
0 | 5,830,203 | 0 $0 | 1 |
Jun 28, 2021
Reduced 100.0%
|